PPARgamma : a nuclear regulator of metabolism, d... [J Biol Chem. 2001] - PubMed

loading

Review PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. [J Lipid Res. 2002]
Review PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism.
Walczak R, Tontonoz P. J Lipid Res. 2002 Feb; 43(2):177-86.
Review [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis]. [Kardiologiia. 2003]
Review [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
Evdokimova MA, Zateĭshchikov DA, Sidorenko BA. Kardiologiia. 2003; 43(11):41-8.
Review Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis. [J Mol Endocrinol. 2001]
Review Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.
Fajas L, Debril MB, Auwerx J. J Mol Endocrinol. 2001 Aug; 27(1):1-9.
Review Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation. [Biochem Pharmacol. 2003]
Review Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Na HK, Surh YJ. Biochem Pharmacol. 2003 Oct 15; 66(8):1381-91.
[Control of cellular differentiation by PPARs]. [Journ Annu Diabetol Hotel Dieu...]
[Control of cellular differentiation by PPARs].
Grimaldi PA. Journ Annu Diabetol Hotel Dieu. 2001; :11-21.

Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics. [Drug Des Devel Ther. 2013]
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.
Liu L, Ma Y, Wang RL, Xu WR, Wang SQ, Chou KC. Drug Des Devel Ther. 2013; 7:279-88. Epub 2013 Apr 8.
Extensive alternative splicing of the repressor element silencing transcription factor linked to cancer. [PLoS One. 2013]
Extensive alternative splicing of the repressor element silencing transcription factor linked to cancer.
Chen GL, Miller GM. PLoS One. 2013; 8(4):e62217. Epub 2013 Apr 16.
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. [Cell Death Dis. 2013]
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes.
Rippo MR, Babini L, Prattichizzo F, Graciotti L, Fulgenzi G, Tomassoni Ardori F, Olivieri F, Borghetti G, Cinti S, Poloni A, et al. Cell Death Dis. 2013 Apr 18; 4:e594. Epub 2013 Apr 18.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth.
PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth.
J Biol Chem. 2001 Oct 12 ;276(41):37731-4. Epub 2001 Jul 17 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed